Company & Sponsor Intelligence
Ruhr University of Bochum
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed2
Countries1
Therapeutic footprint
anxietyother_psychiatrystroke
Indexed studies
NCT02313493Efficacy and Feasibility of Baby Triple P - a Pilot Study
other_psychiatry · NA
other_psychiatry · NA
NCT01273935Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
stroke · GermanyCOMPLETED
stroke · GermanyCOMPLETED
NCT01680237Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia
anxiety · GermanyNA
anxiety · GermanyNA
NCT01843361Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study
stroke · GermanyCOMPLETED
stroke · GermanyCOMPLETED
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →